The effects of different medication schemes of recombinant human vascular endostatin and paclitaxel on the growth of breast cancer SK BR 3 cell in vitro

doi:10.3969/j.issn.1002-7386.2018.21.009

Home>Articles>The effects of different medication schemes of recombinant human vascular endostatin and paclitaxel on the growth of breast cancer SK BR 3 cell in vitro

DOI: 10.3969/j.issn.1002-7386.2018.21.009

The effects of different medication schemes of recombinant human vascular endostatin and paclitaxel on the growth of breast cancer SK BR 3 cell in vitro

Machine-generated Keywords：

Publication Date：2018-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 3241-3244,3248 )

Hebei Medical Journal

ISTIC

ISSN：1002-7386

Year, Vol.(Issue)：2018,40(21)